SUTROVAX INC has a total of 19 patent applications. It decreased the IP activity by 37.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Brazil and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are EFFIK S A, ZHANG JIN JUN and VOUDOURIS VASILIOS.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Brazil | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | Israel | 2 | |
#6 | Republic of Korea | 2 | |
#7 | United States | 2 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Chan Wei | 10 |
#2 | Fairman Jeffery | 9 |
#3 | Heinrichs Jon | 9 |
#4 | Fairman Jeff | 4 |
#5 | Jeffery Fairman | 3 |
#6 | Jon Heinrichs | 2 |
#7 | Wei Chan | 2 |
#8 | Marcq Olivier Jean Gérard | 1 |
#9 | Marcq Olivier | 1 |
#10 | Behrens Christopher | 1 |
Publication | Filing date | Title |
---|---|---|
US2020054739A1 | Conjugated vaccines | |
WO2020010000A1 | Improved methods for the preparation of immunogenic conjugates | |
WO2020010016A1 | Self-adjuvanted immunogenic conjugates | |
CN111225684A | Periodontitis vaccines and related compositions and methods of use | |
WO2018126229A2 | Polypeptide-antigen conjugates with non-natural amino acids |